Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2026-01-29 @ 3:19 AM
Study NCT ID:
NCT06384820
Status:
WITHDRAWN
Last Update Posted:
2024-07-26
First Post:
2024-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-14
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-06-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-05-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-22
First Submit QC Date:
None
Study First Post Date:
2024-04-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-25
Last Update Post Date:
2024-07-26
Last Update Post Date Type:
ACTUAL